Fox Business - The Power to Prosper
Search Site

Biotechnology

Dow, S&P close at record high

Adviser Investment Management Chief Investment Strategist Jim Lowell, A&G Capital CIO Hilary Kramer and Trading Advantage Senior Market Strategist Scott Bauer on the outlook for the markets and where the opportunities are for investors.

Read More

  1. Airline stocks the best way for investors to play the Ebola crisis?

    FBN’s Charles Payne, Tea Party News Network News Director Scottie Nell Hughes, A&G Capital CIO Hilary Kramer, NewOak Capital President James Frischling, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on Ebola stocks for investors’ portfolios.

  2. Will turbulence continue on Wall Street?

    Hedgeye Risk Management Founder and CEO Keith McCullough and Skybridge Capital Founbder Anthony Scaramucci discuss what to expect from and how to invest in volatile markets.

  3. Government waste: Feds spend millions getting monkeys drunk

    FBN’s Charles Payne, CapitalistPig.com founder Jonathan Hoenig, Tea Party News Network News Director Scottie Nell Hughes, Divine Capital CEO Dani Hughes, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on government spending.

  4. Where should investors put their money?

    Ameriprise Financial Chief Market Strategist David Joy and Lisa Shalet, Morgan Stanley’s head of investment and portfolio strategies, discuss their recommendations for investors.

  5. Chrysler makes NYSE debut

    FBN’s Liz MacDonald breaks down IPOs to watch this week.

  6. How much money have Payne’s picks made you this week?

    FBN’s Charles Payne, Penn Financial Group Founder & President Mathew McCall, A &G Capital CIO & President Hilary Kramer, Newoak Capital President J Frischling, and Author Hitha Prabhakar weigh in on Payne’s stock report card.

  7. Is Apple a good stock for your portfolio right now?

    FBN’s Charles Payne, NewOak Capital President James Frischling, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall respond to a viewer’s question about the stock mix in his portfolio.

  8. Businesses facing tech

    Nuveen Asset Management chief equity strategist Bob Doll and Janney chief investment strategist Mark Luschini on businesses investing in tech and the state of Europe’s economy.

  9. Midday Market Report: 10/8/14

    Family of Anna Short Harrington, the original Aunt Jemima, suing Quaker Oats

  10. Monsanto posts wider-than-expected loss in 4Q

    Earnings HQ: FBN’s Lori Rothman breaks down Monsanto’s fourth-quarter earnings report.

  11. What record IPOs say about the market

    FBN’s Liz MacDonald and Telis Demos of The Wall Street Journal discuss the IPO market.

  12. Where is the growth?

    Wells Fargo chief portfolio strategist Brian Jacobsen discusses growth in the markets.

  1. Prices at the pump plunge

    FNC’s James Rosen on the economic forces driving down gas prices.

  2. Fed ready to stop bond-buying program?

    CenterState Bank Executive V.P. Joe Keating, ETFTrends.com publisher Tom Lydon and SFG Alternatives CIO Larry Shover on the markets and Facebook’s third-quarter results.

  3. The race to find an Ebola vaccine

    GeoVax CEO Robert McNally on efforts to find a vaccine for Ebola.

  4. Earnings season scorecard

    Estimize director Christine Short weighs in on U.S. earnings so far.

  5. Art Nunes: Health care is a great sector to be in for long-term

    Northwest Asset Management Portfolio Manager Art Nunes on the sectors that should be on investors’ radar.

  6. Will U.S. markets continue to sell off?

    Emerald Asset Management CEO Joe Besecker and Cantor Fitzgerald U.S. Equities Head Bill Nichols on the markets, volatility and small and mid-cap stocks.

  7. Markets following October’s historic volatility?

    Altaira Senior Managing Director Ralph Acampora on the October markets.

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL